Assessing the current practice of tuberculosis (TB) screening in HIV-infected persons by Ganesh, Rochelle Aneeta
Assessing the Current Practice of Tuberculosis (TB) Screening in HIV-infected Persons 
at Mount Ayliff Hospital 
 
 
 
Rochelle Aneeta Ganesh 
 
 
 
 
Assignment submitted in partial fulfilment of the requirement for the degree of Master of 
Philosophy (HIV/AIDS Management) at Stellenbosch University 
 
 
 
 
 
 
 
 
 
 
Africa Centre for HIV/AIDS Management 
Faculty of Economic and Management Sciences 
Study Leader:  Dr Greg Munro 
March 2011 
2 
 
Declaration 
 
By submitting this assignment electronically, I declare that the entirety of the work 
contained therein is my own, original work, that I am the sole author thereof (save to the 
extent explicitly otherwise stated), that reproduction and publication thereof by 
Stellenbosch University will not infringe any third party rights and that I have not previously 
in its entirety or in part submitted it for obtaining any qualification. 
 
Signature: RA Ganesh 
 
Date:  7 February 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © 2011 Stellenbosch University 
All rights reserved 
3 
 
Acknowledgements 
 
I would like to acknowledge the following: 
 My study leader, Dr Greg Munro  
 Dr NA Amanambu 
 Mount Ayliff Hospital Health Care Professionals who agreed to participate in this 
study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
Abstract 
 
The delayed diagnosis of a curable disease such as TB contributes to the morbidity and 
mortality of HIV-infected persons in South Africa. The life-time risk for active TB in an HIV-
negative person is 5–10%, while the annual risk in HIV-infected persons is up to 15%.   The 
risk of developing TB in HIV-infected persons can be reduced by as much as 60% with an 
integrative approach to HIV/AIDS and TB.  The health care environment can pose a risk with 
regard to TB transmission. TB infection control aims to provide a safe health care 
environment for both patients and HCPs.   
 
The aim of the study was to establish the current practice of TB screening in HIV-infected 
persons in Mount Ayliff Hospital in order to provide guidelines for the clinical management 
of TB in HIV-infected persons. 
 
 The research study focussed on TB transmission and risk; infection control and practice and 
integrated HIV/AIDS and TB services in the area of work.   The current practice of TB 
screening in HIV-infected persons in Mount Ayliff Hospital is poorly aligned to the National 
TB Infection Control policy.  The integration of HIV/AIDS and TB services has not been fully 
implemented.  Formulation of an institutional TB infection control plan that includes regular 
occupational audits may assist in the development of guidelines for the management of TB.   
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Opsomming 
 
Die vertraagde diagnose van ‘n geneesbare siekte, soos TB, dra by tot die morbiditeit en 
morataliteit/dodetal van MIV-geinfekteerde persone in Suid-Afrika. Die leeftydsrisiko vir 
aktiewe TB in ‘n MIV-negatiewe person is 5-10%, terwyl die jaarlikse risiko van MIV-
geinfekteerde persone, tot 15% is. Die risiko van die ontwikkeling van TB in MIV-
geinfekteerde persone kan verminder word met soveel as 60%, met ‘n geïntegreerde 
benadering tot MIV/VIGS en TB. Die gesondheidsorgomgewing kan ‘n gevaar inhou met 
betrekking tot TB-oordrag. Die beheer van TB-infektering beoog om ‘n veilige 
gesondheidsorg-omgewing te skep vir beide pasiënte en gesondheidsorg-werkers. 
 
Die doel van die studie was om die huidige gebruik van TB-sifting in MIV-geinfekteerde 
persone in Mount Ayliff Hospitaal te bepaal met die die doel om riglyne te voorsien vir die 
kliniese hantering van TB in MIV-geinfekteerde persone. 
 
Die navorsing het gefokus of TB-oordrag en risiko, besmettingsbeheer en geïntegreerde 
MIV/VIGS en TB-dienste in die gebied van werk. Die huidige gebruik van TB-sifting in MIV-
geinfekteerde persone in Mount Ayliff Hospitaal is swak ten opsigte van die Nasionale TB-
infeksie beheerbeleid. Die integrasie van MIV/VIGS en TB-dienste is nog nie ten volle 
geïmplimenteer nie. Die vorming van ‘n institutionele TB-infeksie beheerbeleid, wat 
gereelde beroepsoudits insluit, kan help met die ontwikkeling van riglyne vir die bestuur van 
TB. 
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Chapter I 
Introduction and background 
In an international report by the HIV/TB Global Leaders Forum, it has been reported that 
Tuberculosis (TB) is the leading cause of death in South Africa (Statistics South Africa, 
October 2008).  In the context of the HIV epidemic, in which an estimated 5.7 million people 
were living with HIV and AIDS in 2009 (UNGASS, March 2010), the burden of these two 
diseases in South Africa is more than any other country.   
Persons living with HIV are at an accelerated risk of developing active TB due to a weakened 
immune system.  This means that HIV infection facilitates the development of TB and in the 
same way, TB can accelerate HIV progression to AIDS.  The WHO reports on Global 
Tuberculosis Control reports that in countries with high HIV prevalence, TB has tripled in the 
past 15 years, clearly demonstrating that HIV and TB disease are linked (WHO, 2009).   
At the 2010 South African TB Conference in Durban , South African Health Minister Dr Aaron 
Motsoaledi confirmed that South Africa’s TB epidemic was among the worlds’ most severe 
with South Africa having the highest co-infection rates of TB and HIV. As South Africa 
accounts for 0.7% of the global population, this means that of this total population, 28% of 
people living with HIV and TB are in South Africa alone.   This dual epidemic is a public 
health emergency.   
The call for an integration of HIV/TB services remains a challenge in South Africa and the 
National TB Strategic Plan 2007-2011 on integrating these services is yet to be implemented 
(Government of South Africa, March 2007).  Pilot programmes around South Africa agree 
that integrating HIV and TB systems means it is easier for people with one disease to be 
tested and treated for the other. The success of the HIV/TB service integration is such that 
the Western Cape has adopted this as policy. In 2007 over one-third of South African HIV-
positive TB patients were provided with antiretroviral therapy and two-thirds received Co-
Trimoxazole prophylaxis in 2007. The WHO has stated that “collaborative TB/HIV activities 
are being scaled up across the country” (WHO, 2009). 
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The international medical charity, Medicines Sans Frontiers (MSF) began integrating HIV and 
TB services five years ago and reports that integrating HIV and TB services has improved 
case detection, decreased the number of patients lost to follow up , and increased the 
proportion of co-infected patients on Antiretroviral Therapy (ART) (Activists call for 
integrated HIV/TB Services, South Africa,  June 2010).  This suggests that routine screening 
for TB in infected persons, earlier testing and diagnosis of TB will support each programme 
and achieve greater levels of adherence and cure rates with adoption of Directly Observed 
Treatment Short-course (DOTS) and adherence strategies and help to control the rising 
threat of resistant TB in South Africa.   
 Background 
The delayed diagnosis of a curable disease such as TB contributes to the morbidity and 
mortality of HIV-infected persons in South Africa.  HIV has resurrected TB as a global health 
concern, while TB has amplified the mortality from HIV substantially (Dye, 2006).  A cohort 
study in South African Gold Miners found the risk of TB doubles within a year of infection of 
HIV (Sonnenberg et al, 2005).  This early increase in risk was sustained and increased slightly 
during the following years, and assumed to increase during later years as CD4 cell counts 
decrease further (Antonucci et al, 1995; Badri et al, 2002).   
 
It is estimated that HIV-infected persons have an annual 10% chance of developing TB 
throughout their natural life (Riley, 1993).  More than 65% of all active TB patients are co-
infected with HIV, and TB is the leading cause of morbidity and mortality among HIV-
infected patients (Mukadi et al, 1999).  Despite the widespread availability of TB treatment, 
TB/HIV co-infected patients have an annual mortality rate of 25-40% before the introduction 
of Antiretrovirals (ARV) (Mukadi et al, 1999; Connolly et al, 1999).   This mortality was 
attributable to both complications from overwhelming TB disease and immunosuppression 
from advance HIV disease (Murray et al, 1999; Lawn et al, 2005).  
 
Tuberculosis can occur at any point in the course of HIV infection. Pulmonary tuberculosis is 
the most common manifestation of tuberculosis in adults infected with HIV.  
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All patients presenting with clinical symptoms of TB that include cough, excessive weight 
loss over three months and night sweats must be screened for TB.  HIV-infected persons 
newly initiated on ARVs have an increased risk of TB infection known as Inflammatory 
Immune Reconstitution Syndrome (IRIS) especially in the first six months after initiation.  
The risk of developing TB in HIV-infected persons can be reduced by as much as 60% with an 
integrative approach to HIV/AIDS and TB.  
 
The National TB Management Guidelines allude to HIV/AIDS treatment guidelines in that all 
HIV-infected patients should be symptomatically screened and tested for TB at every clinical 
visit with ongoing adherence counselling and support.   This will help reduce morbidity and 
mortality of co-infected clients and help improve treatment outcomes. Patients diagnosed 
with TB should also be offered and screened for HIV and access on-going HIV care.  The 
National ART Guidelines allude to the TB guidelines in addressing TB as a common co-
morbid illness with HIV.    HIV positive patients are at higher risk of developing TB compared 
to the general population, especially during the period immediately after initiating ART. All 
patients with HIV should be screened for TB.  It is very important to investigate patients for 
tuberculosis before starting ART and to routinely screen patients on ART. 
 
Interventions to support the operational function of HIV/AIDS and TB programmes include 
complementing current treatment practice with an awareness of TB preventive therapy, 
strengthening supervision of treatment using DOTS system and enhanced treatment 
adherence strategies.  Integrated HIV/AIDS and TB management clinical interventions 
include intensified case-finding and screening of all HIV-infected persons for TB and all TB 
infected persons for HIV at all hospital visits.   
 
The early diagnosis of TB in HIV-infected persons followed by immediate initiation of 
treatment will strengthen and improve TB treatment completion and higher cure rates, 
reduce the TB burden, support ART scale-up and provide HIV care and therapy to a greater 
number of persons and their quality of life. 
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Research Problem  
In order to detect and diagnose TB prior to advanced HIV immunosuppression, Health Care 
Professionals (HCPs) must be aware of the clinical and non-clinical symptoms that may 
increase the risk of TB infection in HIV-infected individuals.  All too often these symptoms 
may be masked by HIV infection and/or opportunistic infections.  Complacent practice may 
miss opportunities for early diagnosis and treatment of TB by only testing persons who 
significantly present with clinical symptoms of TB instead of actively screening all HIV-
infected persons at every medical evaluation for TB.      
Adherence to treatment of co-infection HIV/AIDS and TB disease are influenced by multiple 
factors that relate to the individual, the disease and treatment and the health service, and 
HCPs must be acutely aware of all factors when screening and educating persons living with 
HIV/AIDS.  That TB accelerates HIV disease progression means that preventing TB among 
HIV-infected persons will work towards preventing morbidity and mortality attributed to TB 
and prolong their survival.   
A keen awareness of transmission of TB within HIV services, in waiting areas and amongst 
in-patients and a consistent TB screening practice of all HCPs and infection control 
interventions that include triaging patients, scheduling new and follow-up patients 
separately, cough hygiene and the use of personal respirators by HCPs and patients alike will 
make an impact on clinical outcomes and treatment goals in HIV/AIDS and TB programmes.  
Notwithstanding the lack of resources, the attainment of the national TB goals and, the 
extent to which National Guidelines are translated into working programmes and integrated 
into HIV/AIDS and TB services, and actively practiced by HCPs at every medical evaluation 
within health institutions, is not known.    
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Research Question 
To what extent do Health Care Providers (HCPs) actively screen for TB in HIV-infected 
persons as stated in the National TB Management Guidelines? 
 
Aim 
To establish the current practice of TB screening in HIV-infected persons in Mount Ayliff 
Hospital in order to provide guidelines for the clinical management of TB in HIV-infected 
persons. 
 
Objectives 
 To analyse the current policy and treatment guidelines for management of TB in HIV-
infected persons 
 To establish the current practice of HCPs in actively screening for TB in HIV-infected 
persons 
 To identify discrepancies between the current policy and treatment guidelines and 
current practice and the institution HIV/AIDS and TB programmes 
 To provide guidelines for the screening of TB in HIV-infected persons 
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Chapter II 
 
Literature Review 
Until the last part of the twentieth century, tuberculosis (TB) was a major cause of death in 
both developed and developing countries. Due to a range of factors such as the human 
immunodeficiency virus (HIV) epidemic, population growth, migration, socioeconomic 
changes, and broad spread of aggressive and resistant new strains such as the Beijing and W 
strains, a resurgence of TB has occurred, even in low endemic areas (Dolin et al,1994).   
 
In 1993, the World Health Organization (WHO) declared a state of global emergency for TB 
due to the steady worldwide increase in the disease. Along with HIV and malaria, TB has 
been declared a global enemy. In 2005, 12 million new cases of tuberculosis were identified, 
a 58% increase from the 7.5 million estimated cases in 1990, and it was estimated that in 
2005 the disease caused 1.5 million deaths worldwide (WHO, 2005). 
 
The goal of TB control programs is to arrest transmission within the community. Achieving 
this goal takes considerable time, because most individuals in endemic areas are already 
infected, constituting a reservoir that continuously contributes to the pool of infectious 
cases. An effective TB control program requires early diagnosis and immediate initiation of 
treatment. Delay in diagnosis is significant with regard to not only disease prognosis at the 
individual level but also transmission within the community and the reproductive rate of the 
TB epidemic (Dye et al, 1999; Bjune, 2005). 
 
Human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and 
tuberculosis (TB) are overlapping epidemics that cause an immense burden of disease in 
sub-Saharan Africa (Harries et al. 2009). 
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In many parts of sub-Saharan Africa, tuberculosis (TB) has been endemic for many decades 
and transmission has been enhanced by overcrowding and poor living conditions. The 
advent of the human immunodeficiency virus (HIV) epidemic has increased the burden of TB 
significantly, as untreated HIV infection leads to progressive immune deficiency and  
increased susceptibility to infections such as TB. In Southern Africa, TB is the leading cause 
of mortality in HIV-infected persons and HIV is driving the TB epidemic. Human 
immunodeficiency virus is the strongest factor capable of promoting progression of 
Mycobacterium tuberculosis (MTB) infection to active tuberculosis (Rieder et al. 1989) both 
in people with recently acquired and latent MTB infections (Maher et al. 2002). The life-time 
risk for active TB in an HIV-negative person is 5–10%, while the annual risk in HIV-infected 
persons is 5–15% (Von Reyn 1999). 
 
Sub-Saharan Africa bears the brunt of the overlapping epidemics of the human 
immunodeficiency virus (HIV) and tuberculosis (TB). Countries in Southern Africa are 
particularly affected, with over 50% of TB patients diagnosed each year being co-infected 
with HIV (Corbett et al.2003; WHO, 2007).  HIV-TB co-infected patients treated only with 
standardised anti-tuberculosis chemotherapy have poor outcomes compared with patients 
who only have TB. Case fatality rates are higher (Harries et al.2001) and in patients who 
complete treatment there is a higher rate of recurrent TB (Korenromp et al.2003).   
 
Research shows that even in areas where there is a good TB control programme, when the 
sero-prevalence of HIV is >20%, the annual percentage increase in TB will be high at over 
10% (Cantwell and Binkin 1996). However, TB accelerates HIV disease progression and is 
associated with decreased survival. TB specific mortality is fourfold higher among HIV-
infected patients than amongst the uninfected (17.8 and 4.4 deaths per 100 per year for 
HIV-infected and uninfected patients, respectively) (Connolly et al. 1999). In addition, the TB 
epidemic in persons infected with HIV increases the infectious pool and the risk of TB 
transmission in the community, whether or not HIV-infected (Maher et al. 2002). Clinical 
interventions have demonstrated that the burden of TB can be reduced in persons infected 
with HIV (Anderson & Maher 2001). 
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Despite the growing evidence base and the WHO's resounding calls for a stronger 
connection between TB and HIV care, many of the hardest hit countries have been slow to 
implement these recommendations on a wide scale(WHO, 2008). 
 
KwaZulu-Natal (KZN), home to nearly 10 million people, is one of the poorest provinces in 
South Africa and is at the epicentre of the HIV and TB pandemics. In 2006, the incidence of 
TB in KZN was 1076/100000 (Day et al.2007), the HIV prevalence was 39.1% (Department of 
Health, South Africa, 2006) and 80% of TB patients were co-infected with HIV (Gandhi et al. 
2006).   
 
Despite an HIV-TB co-infection rate of approximately 75% in some settings(Global TB/HIV 
Working Group, 2007), the SA National TB Control Programme (SANTCP) and HIV/AIDS 
control efforts remain largely separate. 
 
As ART services expand (WHO, 2005), the burden of TB diagnosis or exclusion in HIV-
infected individuals may necessitate the utilization of less trained personnel in resource-
limited settings. Such staff need simple, efficient and inexpensive clinical algorithms that 
could be used to identify those at risk for active TB. This could improve the efficiency of TB 
screening and allow more efficient use of relatively expensive diagnostic procedures. A 
previous study has shown that, in a population with advanced HIV disease in South Africa, a 
screening instrument of two or more symptoms of weight loss, cough lasting >2 weeks, 
night sweats, or fever lasting >2 weeks, was highly sensitive (100%) and specific (88%) for TB 
diagnosis (Mohammed et al.2003). 
 
In the article by Perumal et al. 2009, he stated that the transformation of the TB landscape 
by HIV, demands a public health response that extends well beyond the traditional 
boundaries of TB control. Similarly, HIV cannot be adequately managed if its' intimate 
relationship with TB is not reflected in HIV services. The public health response to HIV has 
focused on individuals and safely guarded their right to confidentiality. This inclination 
toward the rights of the individual with minimal focus on the competing rights of the 
community is maintained throughout the spectrum of HIV care. The response to TB has 
always been quite different with the historical response including many restrictions to 
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personal rights. Patients were "institutionalized" and subjected to the necessary treatment 
in a seemingly paternalistic manner. While much has changed in terms of aligning the 
response to TB with human rights, the response still reflects an interest in the competing 
rights of the public, and the need to prevent spread of infection.  Programmes have been 
targeted at communities, and little effort has been made to protect the individual. While TB 
programmes have benefited from initiatives such as care support buddies and tracing of 
defaulters, non-disclosure in HIV presents a barrier to treatment adherence. Moreover, it is 
difficult to shape a public health policy for HIV care with an HIV programme that is 
individual-centred. The individual-centred, rights-based paradigm, which characterizes much 
of the SA National AIDS Policy, therefore remains dissonant with the compelling public 
health approach of TB control.  
 
The high HIV prevalence in TB patients make these patients and health centres a readily 
identifiable cohort and facility for efficiently providing HIV counselling, testing and entry 
into the continuum of HIV care services. Moreover, the high prevalence of HIV in TB 
suspects strengthens the call for an integrated TB-HIV service (Srikantiah et al. 2007). 
 
The full potential of an integrated TB-HIV service has not been fully harvested. Missed 
opportunities discount existing efforts in both programmes, will perpetuate the burden of 
disease, and prevent major gains in future interventions (Perumal et al.2009). 
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Chapter III 
Research Design  
Method 
A qualitative document analysis of the current National and institutional policy and 
treatment guidelines for HIV/AIDS and TB management was conducted and any 
discrepancies between the documents was identified.   
Target material for the document analysis includes HIV/AIDS and TB policy and treatment 
guidelines from the National Department of Health and the Mount Ayliff working 
documents on HIV/AIDS and TB. These were used to analyse information provided and the 
current practice written up for the management of TB in HIV-infected individuals.  All 
documents were selected for the inclusion of TB management in HIV infection. 
 This was followed with a quantitative assessment of the current practice of HCPs in actively 
screening for TB in HIV-infected person.  
Target Group 
Thirty Health Care Providers (HCPs) from Mount Ayliff Hospital were randomly selected for 
the assessment of current practice of TB screening.  The HCPs were selected using random 
number tables of day staff on duty that are not in a position of management, as the 
selection criteria.   
Measuring Instrument 
A self-administered anonymous questionnaire was used to collect data on the current 
practice of HCPs in actively screening for TB in HIV-infected persons. Informed and written 
consent was sought from participants prior to their participation.  The questionnaire and 
consent forms were available in both English and isiXhosa for participants of the research.   
The questionnaire focussed on three themes in areas of work, namely, TB transmission and 
risk; infection control and practice and integrated HIV/AIDS and TB services.   
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Data Analysis 
The document analysis focussed on the content of the National and institutional policy and 
treatment guidelines on HIV/AIDS and TB, and the context which informs each of these, its 
adaptability and practicality for the HCP users at Mount Ayliff Hospital.   
The questionnaire analysis and interpretation assessed the knowledge of TB transmission 
and TB transmission risk in the area of work, assessed infection control and screening 
practices in the area of work environment and those undertaken by the HCPs, and assessed 
awareness and checked understanding about the clinical management of integrated 
HIV/AIDS and TB services in actively screening HIV-infected patients for TB.   
 
Ethical Considerations 
Ethical clearance and consent to perform this research and assessment was sought from the 
University of Stellenbosch Research Ethics Committee: Human Research (Non-Health).  
Approval to conduct this assessment followed consent from Mount Ayliff Hospital 
Management and the Quality Assurance Committee.  All participants of the study were 
approached for voluntary participation and were provided with forms of informed and 
written consent. All information obtained was confidential, used only for the purposes of 
this study after informed and written consent had been gained. 
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Chapter IV 
Results 
 
A total of thirty questionnaires were distributed, twenty-eight were returned and two of 
these were incomplete. Twenty- six questionnaires were analyzed.  
1. What is your occupation? 
Occupation  Frequency % 
Doctor 4 15.4 
Nurse – Out-patients 
department 
6 23.1 
Nurse – Casualty 3 11.5 
Nurse – Wards 7 26.9 
Nurse- ARV 2 7.7 
Pharmacist 2 7.7 
Radiographer 2 7.7 
Total 26 100 
 
The majority of the respondents (69.2%) were nurses.   
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Figure 1: Pie chart showing  occupational group of participants 
 
  
 
 
2.  Which areas are you responsible for? 
 
Area of work Frequency % 
ARV Clinic 3 11.5 
Out-patients Department 8 30.8 
Casualty 3 11.5 
Wards 8 30.8 
Pharmacy 2 7.7 
X-ray Department 2 7.7 
Total 26 100 
 
 
 
Occupation
Doctor
Nurse
Pharmacist
Radiographer
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Figure 2: Pie chart showing area of work of participants 
 
 
3.  How risky is your area of work with regard to TB transmission? 
Table 3:  Number of patients seen daily in area of work 
3.1 Frequency % 
0 – 50 7 26.9 
50- 100 13 50 
>100 6 23.1 
Total 26 100 
 
Table 4: Estimate of TB suspects/ patients seen daily 
3.2 Frequency % 
<5% 7 26.9 
5- 15% 10 38.5 
>15% 9 34.6 
Total 26 100 
 
Area of work
ARV Clinic
OPD
Casualty
Wards
Pharmacy
X-ray Dept.
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From the data, the majority of patients are seen by nurses in the Out-patients Department 
and the Wards.   
 
Table 5:  Average patient waiting time in area of work 
3.3 Frequency % 
0-1 hour 3 11.5 
1-2 hours 6  23.1 
>2 hours 17 65.4 
Total 26 100 
 
65.4% respondents reported that the average patient waiting time in their work area as >2 
hours.  This was mainly staff in the Out-patients department.  23.1% reported patient 
waiting time of between 1-2 hours and 11.5% less than 1 hour.   
 
Table 6:  Rate of ventilation in area of work 
3.4 Frequency % 
Good 4 15.4 
Average 8 30.8 
Bad 14 53.8 
Total 26 100 
 
15.4% thought that the airflow/ventilation was good in the area of work, 30.8% thought that 
the airflow/ventilation was average and 14 (53.8%) thought it was bad.   
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Figure 3: Bar chart showing how risky the work area is with regard to TB transmission 
 
 
 
4: Strategies to reduce generation of infectious aerosol (administrative controls)  
 
Table 7:  TB Screening of patients 
4.1 Frequency % 
Yes 7 26.9 
Occasionally 12 46.2 
No 7 26.9 
Total 26 100 
 
46.2% of respondents occasionally screen for TB in patients who present with cough > 2 
weeks as they enter the facility.  It was found that the more likely staff category compliant 
with TB screening practices are the doctors and most nurses occasionally screen for TB.   
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Table 8:  Cough Hygiene 
4.2 Frequency % 
Yes 9 34.6 
Occasionally 4 15.4 
No 13 50 
Total 26 100 
 
34.6 % of respondents educate patients in cough hygiene if they are coughing.  50 % of 
respondents do not educate patients in cough hygiene if they are coughing.    
 
Table 9: Provision of masks/tissues to patients 
4.3 Frequency % 
Yes 5 19.2 
Occasionally 6 23.1 
No 15 57.7 
Total 26 100 
 
Majority of the respondents (57.7 %) do not provide patients who are coughing with 
masks/tissues to reduce generation of infectious aerosol in the hospital.  This could be due 
to the erratic availability of masks/tissues in the hospital. 
 
 
 
 
 
 
27 
 
Table 10:  Isolation of TB suspects/patients 
4.4 Frequency % 
Yes – consistently isolated 5 19.2 
Occasionally isolated 2 7.7 
Not isolated 19 73.1 
Total 26 100 
 
73.1 % of respondents report that patients who are TB suspects/patients are not isolated / 
separated from those who are.   
 
Table 11:  Priority to TB suspects to decrease waiting times in out-patient facilities 
4.5 Frequency % 
Yes 2 7.7 
Occasionally 9 34.6 
No 15 57.7 
Total 26 100 
 
TB suspects are given priority to shorter waiting times in the Out-patients Department 
occasionally (34.6 %).  57.7 % of respondents do not prioritize patients who are TB suspects.   
 
Table 12: Staff awareness of need for early TB diagnosis 
4.6 Frequency % 
Yes 6 23.1 
No 20 76.9 
Total 26 100 
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20 (76.9 %) of the respondents are not aware of aware of the need for early TB diagnosis.  
The ARV clinic is more likely to comply with the awareness through staff training. 
Table 13:  Separate and ventilated facilities for sputum collection from TB suspects  
4.7 Frequency % 
Yes 3 11.5 
Yes, but not ventilated 2 7.7 
No 21 80.8 
Total 26 100 
 
There are no designated separate and ventilated facilities for sputum collection. This is 
reported by 21 of the respondents. 
 
Table 14:  Fast-queue for collection of sputum results 
4.8 Frequency % 
Yes 5 19.2 
No, but collection of results is fast 8 30.8 
No 13 50 
Total 26 100 
 
There is no fast-queue for collection of sputum results. This is represented by 50 % of the 
respondents, 30.8 % do not have a fast-queue but expedite collection of results. 
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Table 15:  Laboratory turn-around time for sputum testing 
4.9 Frequency % 
>48 hours 6 23.1 
48-72 hours 15 57.7 
>72 hours 5 19.2 
Total 26 100 
 
57.7 % of sputum results have a turn-around time of 48-72 hours. 
Figure 4: Bar chart showing the strategies to reduce the generation of infectious aerosol 
(administrative controls) 
 
 
Key:   
 Box 1:  Regular staff training 
 Box 2: Occasional staff training 
 Box 3:  No staff training 
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5: Strategies to reduce/eliminate infectious aerosol after generations (environment 
control) 
Table 16:   Time spent outside 
5.1 Frequency % 
Yes 5 19.2 
Occasionally 12 46.2 
No, it’s not possible 9 34.6 
Total 26 100 
 
19.2 % of respondents reported that TB inpatients are able and encouraged to spend time 
outside during daylight hours.  46.2 % reported that the inpatients were occasionally 
encouraged to spend time outside.  For 34.6 % of the respondents, this was not possible.  
These responses were found to be from the X-ray, Maternity and Pharmacy departments. 
 
Table 17:  Windows able to open 
5.2 Frequency % 
Yes 22 84.6 
Some 2 7.7 
No 2 7.7 
Total 26 100 
 
22 (84-6 %) respondents reported that all of the windows are open in their area of work all 
the time.  7.7 % reported that the windows were open some of the time and 2 (7.7 %) 
reported not at all.   
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Table 18:  Windows kept open 
5.3 Frequency % 
Yes 8 30.8 
Occasionally 11 42.3 
No 7 26.9 
Total 26 100 
 
8 (30.8 %) respondents reported that all of the windows were kept open in their area of 
work all the time.  42.3 % reported that the windows were kept open some of the time and 
7 (26.9 %) reported no windows open at all.   
 
Table 19:  Fans Used 
5.4 Frequency % 
Yes 4 15.4 
Occasionally 6 23.1 
No 16 61.5 
Total 26 100 
 
4 (15.4 %) respondents reported that fans were used to increase circulation of air in their 
area of work.  23.1 % reported that the fans were used some of the time and 16 (61.5 %) 
reported no fans were used.   
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Table 20:  Direction of air-flow 
5.5 Frequency % 
Yes 3 11.5 
Yes, but I don’ t always 6 23.1 
No 17 65.4 
Total 26 100 
 
17 (65.4 %) respondents were not aware that during consultation or work with patients, the 
direction of the air-flow should be towards the patient and from behind them.  These were 
nurses, X-ray and Pharmacy Department respondents.  23.1 % reported that the knowledge 
is present, but that they do not always practice it.   
 
Table 21:  Use of UV radiation 
5.6 Frequency % 
Yes 4 15.4 
Occasionally 4 15.4 
No 18 69.2 
Total 26 100 
 
4 (15.4 %) respondents reported that UV radiation facilities were used in their area of work.  
This response was from the Out-patients Department.   A total of 69.2 % reported no UV 
radiation facilities were used in their area of work; these were X-ray, Maternity and 
Pharmacy Departments.   
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Figure 5: Bar chart showing the strategies to reduce/eliminate infectious aerosol after 
generation (environmental controls) 
 
Key:   
 Box 1:  Regular staff training 
 Box 2: Occasional staff training 
 Box 3:  No staff training 
 
6.  Strategies to reduce inhalation of infectious aerosols (personal protective equipment)  
 
Table 22: TB screening as a part of conditions for employment 
6.1 Frequency % 
Regularly 4 15.4 
No, but I have done this in my personal capacity 4 15.4 
No 18 69.2 
Total 26 100 
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18 (69.2 %) respondents reported that they are not being screened for TB infection and 
disease as part of routine employment conditions.  15.4 % reported screening for TB 
screening and disease in their personal capacity.   
 
Table 23:  Encouragement of staff to know individual HIV status 
6.2 Frequency % 
Yes, regularly 6 23.1 
Occasionally 4 15.4 
No, not at all 16 61.5 
Total 26 100 
 
16 (61.5 %) respondents reported that they are not regularly encouraged by their line 
mangers to know their HIV status.  15.4% reported that they are occasionally encouraged to 
know their HIV status.  23.1 % are always encouraged to know by their line managers to 
know their HIV status. 
 
Table 24: Staff awareness of risks of TB infection and disease to people living with HIV 
6.3 Frequency % 
Yes 23 88.5 
Some  knowledge 3 11.5 
No 0 0 
Total 26 100 
 
23 (88.5 %) respondents were aware of the risks of TB infection and disease to people living 
with HIV.  11.5 % reported having some knowledge of the associated risks, this was the X-
ray department. 
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Table 25: Staff trained in TB infection Control 
6.4 Frequency % 
Regularly trained 4 15.4 
Occasionally trained 8 30.8 
Not trained 14 53.8 
Total 26 100 
 
14 (53.8 %) respondents were not trained in TB infection control. 30.8 % have received 
some training and 15.4 % were always trained in TB infection control.   
 
Table26:  Training of staff in recognition of TB suspects and TB diagnosis 
6.5 Frequency % 
Regularly trained 6 23.1 
Occasionally trained 11 42.3 
No training at all 9 34.6 
Total 26 100 
 
9 (34.6 %) respondents were not trained in recognition of TB suspects and diagnosis of TB.  
42.3% have received partial training and 23.1 % have received training in recognition of TB 
suspects and diagnosis of TB. 
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Table 27:  Availability of N95 masks 
6.6 Frequency % 
Yes, always 10 38.5 
Yes, occasionally 7 26.7 
No 9 34.6 
Total 26 100 
 
9 (34.6%) respondents reported that N95 masks were never available for use; this was 
mainly staff from X-ray and Pharmacy Departments.  38.5% reported available N95 masks 
and 26.7 % reported that N95 masks were not always available. 
 
Table 28:  Staff trained in the use of N95 masks 
6.7 Frequency % 
Yes, always 8 30.8 
Occasionally 4 15.4 
No, not at all 14 53.8 
Total 26 100 
 
53.8% reported that they were never trained in the use of N95 masks.  15.4% had received 
some training, and 30.8% were adequately trained in the use of N95 masks. 
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Table 29:  Active use of N95 masks by staff 
6.8 Frequency % 
Yes, always 4 15.4 
Occasionally 9 34.6 
No, not at all 13 50 
Total 26 100 
 
Half of the respondents do not use the N95 masks at all in their areas of work.  This was 
mainly staff from Out-patients, Pharmacy, X-ray and Casualty Departments.  34.6% 
occasionally use the N95 masks during work.  15.4% always use the N95 masks. 
 
Figure 6: Bar chart showing the strategies to reduce inhalation of infectious aerosols 
(personal protective equipment) 
 
Key:   
 Box 1:  Regular staff training 
 Box 2: Occasional staff training 
 Box 3:  No staff training 
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7. Integrated HIV/AIDS and TB services 
 
Table 30:  Co-infected HIV/TB patients 
7.1 Frequency % 
<5 5 19.2 
 5-15 8 30.8 
>15 13 50 
Total 26 100 
 
Half of the respondents reported that they see >15 co-infected HIV/TB patients daily in their 
area of work.  8 (30.8%) respondents reported they see between 5-15 co-infected HIV/TB 
patients daily and 19.2% reported <5 co-infected HIV/TB patients seen daily in their area of 
work.   
 
Table 31:  Treatment and adherence counselling prior to TB therapy initiation 
7.2 Frequency % 
Yes 6 23.1 
No 20 76.9 
Total  26 100 
 
23.1% of respondents reported providing treatment and adherence counselling to patients 
prior to TB therapy initiation.  This was mainly Doctors and ARV clinic nurses.  76.9% of 
respondents reported never providing treatment and adherence counselling to patients 
prior to TB therapy initiation. 
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Table 32:  Practice DOTS to aid compliance and adherence in patients on ARVs 
7.3 Frequency % 
Always 7 26.9 
No 19 73.1 
Total 26 100 
 
26.9% of respondents reported practicing a DOTS approach to aid compliance and 
adherence in patients on ARVs.  73.1% of respondents reported never practicing a DOTS 
approach to aid compliance and adherence in patients on ARVs.   
 
Table 33:  Screening for HIV in TB patients 
7.4 Frequency % 
Always 9 34.6 
Occasionally 6 23.1 
Usually not 11 42.3 
Total 26 100 
 
34.6% of respondents reported actively screening for HIV in TB patients.  23.1% occasionally 
screen for HIV in TB patients and 42.3% do not actively screen for HIV in TB patients. 
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Table 34:  Screening for TB in HIV patients 
7.5 Frequency % 
Always 7 26.9 
Occasionally 8 30.8 
Usually not 11 42.3 
Total 26 100 
 
26.9% of respondents reported actively screening for TB in HIV patients.  30.8% occasionally 
screen for TB in HIV patients and 42.3% do not actively screen for TB in HIV patients. 
 
Table 35:  Provision of IPT 
7.6 Frequency % 
Always 7 26.9 
Occasionally 11 42.3 
Usually not 8 30.8 
Total 26 100 
 
26.9% of respondents reported that IPT is not provided to HIV patients on ARVs.  42.3% 
occasionally provide IPT to HIV patients on ARVs and 30.8% do not provide IPT. 
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Figure 7: Bar chart showing the integrated HIV/AIDS service 
 
 
 
Key:   
 Box 1:  Regular staff training 
 Box 2: Occasional staff training 
 Box 3:  No staff training 
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Chapter V 
 
Discussion 
The aim of the study was to establish the current practice of TB screening practice in HIV-
infected persons and infection control at Mount Ayliff Hospital.  This was assessed using a 
self-administered questionnaire distributed amongst Health Care Professionals.   
 
5.1  Occupation profile of respondents 
The majority of the respondents were Nurses, who encounter the majority of patients 
accessing the facility and who are most likely to be initiatives of TB screening and infection 
control in patient interactions.  This was followed by Doctors, then Pharmacist and 
Radiographers.   The Out-patient Department and Hospital Wards are the areas most often 
susceptible to infection control measures due to the volume and turnover of patients 
accessing these areas of care and most widely accessed by Doctors and Nurses.   
In-service training of infection control should therefore be prioritised especially towards 
Doctors and Nurses, but should also be integrated into the generic practices and quality of 
care standards and services for all HCPs.   Both the Pharmacy and X-ray Departments are in 
the Out-patients Department, and should be areas of concern that require more attention.    
The ARV clinic is an area in which infection control measures should be stringently practiced 
due to the increased risk and susceptibility of immune-compromised patients to 
opportunistic infections, as well as the risks of re-infection, TB contacts, and drug-resistant 
TB.  Both the X-ray and Pharmacy Departments have intimate contact with all patients that 
require infection control measures in place to eliminate the risk of transmission and 
infection.   
5.2  Risk of TB transmission 
The data displays the risk of TB transmission is highest for the Out-patients Department and 
the Wards, as the majority of patients are seen in these areas by Nurses and Doctors.  The 
number of patients seen daily in these areas implies that these environments require TB 
infection control as a matter of priority. With  5-15%  of these patients categorized as TB 
suspects coupled with an average waiting time > 2 hours implies that the HCPs in these 
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areas are more likely to be exposed to TB suspects and risk of infection, and are also in a 
stronger position to implement TB infection control measures and triage patients effectively 
to reduce risk of transmission.   
The patient waiting time can also be managed more effectively by educating patients about 
cough hygiene; remove coughing patients from non-coughing patients; create a ventilated 
waiting area in sunlight, or outside (weather permitting)  etc.  This also implies that HCPs are 
more likely to be exposed to the risk of TB, and should be exercising personal infection 
control measures as  well.  These patients should be fast-tracked and be attended to, 
reducing the average waiting time.   
The majority of respondents rated ventilation/airflow in the waiting area in their area of 
work as bad, this implies that the area of work with regard to TB transmission is at high risk 
for both patients and HCPs.  Revisiting the airflow to ensure correct circulation and 
extraction  within these areas, as well as triaging patients to reduce congestion may mean 
setting up work environments differently and changing existing infrastructure.    
5.3  Administrative Controls 
Administrative controls should be practiced by all HCPs.  The screening of patients needs to 
become a part of the routine and baseline investigations for all patients, as the data displays 
that it is not practiced routinely by all HCPs.  The data shows that patients who are coughing 
are not educated in cough hygiene or provided with masks/tissues to reduce generation of 
infectious aerosols.  
This is one of most effective ways to reduce TB transmission and its implementation should 
be included in the basic package of care to all patients.  This basic intervention of creating 
awareness amongst both HCPs and patients is core to quality assurance and infection 
control improvement plans and could contribute to the reduction of TB transmission within 
the community as well.  
 The lack of isolation/separation of TB suspects could be due to space constraints and /or 
infrastructure, but again, the practical set-up and arrangement of triage, the use of 
ventilated and sheltered/sunlit outside waiting areas and awareness of cough practice 
would effectively contribute to infection control measures.   
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Both the Out-patients and Wards should work effectively to prioritise TB suspects using the 
triage and fast-track these patients for early diagnosis and treatment if necessary and 
ensure shorter waiting times especially in the out-patient department.   
Staff are not aware of the need for early TB diagnosis, which demonstrates that the 
orientation and rotation of nurses in departments are not engaging in staff and in-service 
training as effectively.  The use of visual mediums and printed flow-charts need to be legibly 
and visibly displayed and enforced by operational and area mangers as well as to ensure the 
flow of communication from management to service level.  
It appears from the data that the expedition of results is standard practice for some 
individuals than for others.  This implies that a platform of social dialogue between 
laboratory and clinical practice needs to be set-up to compliment TB infection control 
measures in reducing waiting times for consultation and investigation and collection of 
results.   
The importance of early TB diagnosis, confirmation of results and treatment initiation 
contributes to higher cure rates, lower mortalities and minimising risk of drug-resistant TB.  
An integrated approach within the multi-disciplinary framework requires the hospital 
management together with laboratory personnel and HAST programme co-ordinators to 
adopt strategic administrative controls within the facility.  It is difficult to monitor 
compliance to the national TB guidelines, but the data clearly displays a lack of compliance 
by HCPs to basic infection control interventions and non-existent measures in place.  
Institutional and in-house policies and protocols are either not implemented or audited to 
discover whether measures are/not in place or practiced poorly or not at all.    
 
5.4  Environmental Controls 
The data demonstrates a lack of consistent engineering controls which impacts the lack of 
administrative controls within the institution.  The environmental controls is a collective 
responsibility, and although the infrastructure is not always present, more work needs to be 
done in consultation with the hospital maintenance and infection control departments.  
There are some patients that are unable to spend time outside, these include bed-ridden, 
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post-surgery and during cold-weather.  However mechanical controls that include the 
arrangement of the area as well as windows, extracting air-conditioners and fans should be 
utilised irrespective of weather. Only the out-patients waiting area has two fans, these are 
not always switched on.  The windows and door in the Out-patients waiting area is kept 
closed during rainy and cold weather.    
The wards have windows on one side only and one entrance for entering/exiting staff and 
visitors.  Most of the windows are not secure and are kept shut due to avoid swinging 
open/shut in windy weather and during cold weather. In-patients lie opposite and across 
each other and there are windows on one side only.  The TB wards are isolated from the 
general wards, but they are along the same corridor for exit/entry of staff, patients and 
visitors.    Both staff and patients require awareness and education on airflow and proper 
circulation and ventilation.   
 In areas such as X-ray department, it is understandable that some mechanical ventilation 
may not be present, in this instance patients should be fast-tracked and personnel should 
have measures in place, that include isolation of patients, separate waiting areas, allocated 
times for x-ray appointments to avoid congestion and mingling of TB suspects with other 
patients. Extractor fans should also be installed.   
The Pharmacy Department has dispensing windows that blow air directly from the 
pharmacy patient waiting area into the pharmacy.  There are no windows in the pharmacy, 
air blows in from both the pharmacy waiting area and the out-patients waiting area and the 
extent to which the air-conditioner extracts and filters the air is undetermined.  There is a 
single entrance/exit in use that is opposite the out-patients waiting area and the traffic of 
staff using this entrance in the collection and delivery of medication is constant.   
Implementation of environmental controls work hand in hand with administrative controls 
and how HCPs practice will affect what is done.  Majority of the respondents were unaware 
of the direction of airflow during consultation.  The data demonstrates that the respondents 
are not aware/informed of practical infection control measures.   
The ARV Clinic should be a strategic priority for the institution due to its size and lack of 
infection control measures.  There are no windows in the waiting area, no fans, a single 
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exit/entrance for staff, patients and visitors, no triage of patients, and a non-extracting air-
conditioner.  This results in long waiting times, high congestion and traffic and poor airflow.  
The high volume of patients accessing this point of care alone daily is an area of high 
concern as well as a high risk for TB transmission and infection.   
5.5  Personal Protective Equipment 
Occupational strategies for TB infection control in the working environment require a 
concerted effort from management and a renewed emphasis on the managerial role of 
occupational health and safety within the working environment. HCPs are at a higher risk of 
infection with TB due to the frequent exposure to patients with infectious diseases.  
Stringent need for screening and infection control practices is also critical because the 
estimated 5-15% of TB suspects seen daily equate to the undiagnosed, untreated and 
potentially contagious TB transmitters who increase the exposure risk even more.  The 
increasing risk of drug-resistant TB is an additional risk for HCPs.  Occupational Health and 
Safety must also ensure that HCPs with HIV-associated immune suppression should be 
placed away from areas of high risk.   
The use of personal protective equipment works in conjunction with administrative and 
environmental controls and if each of these infection control measures are stringently 
implemented  and upheld, it can alleviate the associated risks of contracting TB.   
Personal protection is at a minimal in this institution.  An alarming 69% of respondents have 
not been screened for TB infection and disease which reflects upon the occupational health 
plan as well as on the management of the institution.  TB screening should be a routine part 
of the conditions of employment for all staff and should be conducted at least annually.  At 
least 15% of respondents have been screened in a personal capacity, which displays an 
employee concern about the risk of TB transmission even though the practice is poor.  The 
role of management in providing in-service training, acknowledging the occupational health 
risks and asserting a stronger commitment to how HIV/AIDS and TB affect all employees at 
Mount Ayliff Hospital appears absent. Although most respondents are aware of the risks of 
TB infection and disease to people living with HIV, there is a significant lack of translating 
this knowledge into attitude and practice  in the work environment and in to implementing 
infection control measures.   There has been unanimous acknowledgement consistent in the 
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responses of a need for in-house education and training in TB infection control and practice.   
Respondents display a partial understanding of TB infection control, and lack the education 
and awareness of the importance of standardising infection control measures within the 
work environment.  An overwhelming majority of respondents have never been trained nor 
use the N95 masks in the areas of work, which is critical in a health facility and requires 
immediate revision.  It is the responsibility of management to ensure that protective 
equipment is readily available for all workers and that at all levels, education and training 
occurs.   
5.6 HIV/AIDS and TB integration 
The data demonstrates that based on the volume of patients seen daily at Mount Ayliff 
Hospital, the prevalence of TB within this community is high.  This reinforces the need for TB 
and HIV programmes to become integrated in their approach at all levels.  Screening, testing 
and treating for TB and HIV should be a standard package of care and services.  Mount Ayliff 
Hospital currently provides ART and TB treatment, however due to the confidentiality of 
patient information; the referral system between TB and HIV services is inefficient.  
Complete patient information requires a standardised HIV patient record and care plan 
inclusive of TB screening and treatment.  This will enable HCPs to provide the proper care 
and support required to maintain adherence and achieve greater clinical outcomes.   
50% of respondents interact with co-infected HIV/TB patients daily, and even more lack the 
skills to provide treatment and adherence counselling prior to TB therapy initiation.   The 
integration of HIV/AIDS and TB services seem to fall onto the ARV Clinic nurses and doctors, 
and active screening to HIV in TB and TB in HIV appears to be the responsibility of a few 
instead of all.  This lack of knowledge and practice reveals an increasing need for education 
and awareness on the managerial and service level.   
Interventions include intensified TB case finding which translates to screening HIV-positive 
clients for TB at every clinical visit and all TB treatment patients for HIV.  There should be 
materials available that encourage and support testing for HIV and screening to TB. This also 
means that at every monthly medication visit, patients are screened for TB.    There is a 
need for the institution to develop standard screening protocols to assist in the early 
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detection and diagnosis of TB in HIV-positive patients.  All HCPs need to be trained in TB 
screening especially with regards to extra-pulmonary and smear negative TB.   
 
In 2010, Mount Ayliff Hospital initiated IPT to all HIV-positive patients.  The prevention of 
latent TB developing to active TB amongst PLWHA has been well documented and the drug 
Isoniazid (INH) is used for a period of six months.  INH can be used prior to starting ART or 
during ART, when active TB has been ruled out.  The IPT national policy was documented in 
2002, but has only been implemented in 2010.   
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Chapter VI 
 
Conclusion and Recommendations 
The current practice of TB screening in HIV-infected persons in Mount Ayliff Hospital is 
poorly aligned to the National TB Infection Control policy.  Areas that require immediate 
action includes, effective triage and screening of all patients, intensified TB case finding and 
treatment, ventilation of work environments, ongoing staff education and training on TB 
infection control and appropriate use of N95 masks.   The occupational health plan for all 
employees needs to be reviewed to include annual screening for TB infection and disease, 
voluntary HIV counselling and testing.  It is quite clear that the integration of HIV/AIDS and 
TB services has not been fully implemented.  Programme co-ordinators need to integrate 
programme objectives and strategies forming an integrated and standardised approach that 
will be practiced by all HCPs.   
The results of this research report indicate a need for a working document on TB infection 
control at Mount Ayliff that include the implementation of administrative, environmental 
and personal control measures.  The following recommendations are made: 
 Effective triage of all patients on entry by separating coughing patients from non-
coughing patients, educating patients on cough hygiene, provision of masks/tissues 
to patients 
 Fast-tracking / intensified case detection of TB suspects for early diagnosis and 
treatment and improve the laboratory turn-around time for sputum 
 Improving ventilation by keeping windows open, promote cross ventilation, where 
possible use extractor fans and UV light. 
 Promote the regular use of N95 masks by all staff 
 Create a separated ventilated area for sputum collection 
 Regular staff training on the need for effective TB infection control and integration of 
HIV/AIDS and TB programmes 
 Implementation of DOTS strategy in ARV programme and treatment preparation, pill 
count and adherence counselling for TB patients 
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 Formulation of an institutional TB infection control plan that include regular 
occupational audits 
 Stronger managerial role and involvement in implementation of infection control 
measures 
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Appendices 
 
 
 
 
 
STELLENBOSCH UNIVERSITY 
CONSENT TO PARTICIPATE IN RESEARCH 
 
Assessment of TB screening practices and infection control at Mount Ayliff Hospital 
Population Group: Health Care Professionals at Mount Ayliff Hospital 
 
You are asked to participate in a research study conducted by Rochelle A Ganesh, BPharm 
2007, from Industrial Psychology at Stellenbosch University.  The results from this study will 
contribute towards a thesis.  You were selected as a possible participant in this study 
because of the increasing prevalence of TB in HIV-infected individuals.  As a Health Care 
Professional in your area of work, active TB screening and infection control practices provide 
early opportunities for diagnosis and treatment of TB in HIV-infected individuals, and 
contributes towards strengthening and improving TB treatment completion and higher cure 
rates, reducing the TB burden, supporting ART scale-up and providing HIV care and therapy 
to a greater number of persons and their quality of life. 
 
1. PURPOSE OF THE STUDY 
To establish the current practice of TB screening in HIV-infected persons in Mount Ayliff 
Hospital in order to provide guidelines for the clinical management of TB in HIV-infected 
persons. 
 
2. PROCEDURES 
If you volunteer to participate in this study, we would ask you to do the following things: 
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Complete an anonymous questionnaire on the current practice of Health Care Professionals 
in Mount Ayliff Hospital in actively screening for TB in HIV-infected persons.  The 
questionnaire focuses on these three specific areas or themes in your area of work, TB 
transmission and risk; infection control and practice and integrated HIV/AIDS and TB 
services.   
The questionnaire should be completed individually and returned to Rochelle A Ganesh at 
Mount Ayliff Hospital as soon as it has been completed.  The questionnaire requires 
approximately 20 minutes to complete and requires no additional writing or comment.    
 
3. POTENTIAL RISKS AND DISCOMFORTS 
The questionnaire is anonymous and participants are chosen randomly.  All information 
from the questionnaires will remain confidential and used only for the purpose of this study.  
No information can be used to discredit any individual or the institution.   
 
4. POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
The questionnaire aims to increase awareness of TB transmission and TB transmission risk in 
HIV-infected individuals in Mount Ayliff Hospital, and the personal and environmental 
infection control and screening practices that should be in place.  This increased knowledge 
and awareness by Health Care Professionals can be used to provide guidelines for the 
screening of TB in HIV-infected individuals and inform institution policy and guidelines for 
the clinical management of TB in HIV-infected individuals. The study hopes to benefit Health 
Care Professional practice and can be used for in-service training and orientation of new 
professionals in integrated HIV/AIDS and TB services. 
 
 PAYMET FOR PARTICIPATION 
There is no payment or remuneration for participation in this study.  It is a study to change 
current practice for continued professional development and to increase the quality of 
service offered. 
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5. CONFIDENTIALITY 
Participation in this study requires informed consent from the participant.  This means that 
the purpose and intent of the study must be explained to the participant fully before and 
confirmed by the participant prior to participating.  A copy of the consent form must be 
given to the participant confirming that he/she is aware of the purpose of the study and 
agrees to participate as well as being assured that the study has been approved by the 
institution as well as Stellenbosch University, thus ensuring confidentiality.  The Quality 
Assurance Department of the Hospital will also act to ensure confidentiality of the 
participant. 
  Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential and will be disclosed only with your permission or as 
required by law. Confidentiality will be maintained by means of anonymous questionnaires 
that will be distributed and collected by Rochelle A Ganesh.  Questionnaires will be filed in 
the pharmacy store room in which access to the store is monitored by Rochelle A Ganesh 
and pharmacy staff.  Access to the questionnaires will be limited to Rochelle A Ganesh to 
whom the key to the cabinet will be on her person always. 
The information from the questionnaire will be analysed for the data analysis of the study 
and any information released to the Hospital and Quality Assurance Management will be 
compiled in a report of Hospital Practice and in no way will discredit any person or the 
institution but will serve to highlight the current practices of Health Professionals at Mount 
Ayliff Hospital. 
The distribution of the questionnaires will be overseen by the Quality Assurance 
Management to ensure objectivity and confidentiality of information.  The safe storage of 
questionnaires will be monitored over the data collection period, and the disposal of 
questionnaires will be undertaken by the Quality Assurance Management to ensure 
irretrievability of data collected.   
The total number of questionnaires distributed will be accounted for and any incomplete or 
illegible questionnaires will be disposed by the Quality Assurance Officer.  The anonymity of 
the questionnaires will be stated explicitly when writing up the findings of the study and will 
assert to health practices of the institution and no one person. 
 
6. PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not.  If you volunteer to be in this study, you 
may withdraw at any time without consequences of any kind.  You may also refuse to 
answer any questions you don’t want to answer and still remain in the study. The 
investigator may withdraw you from this research if circumstances arise which warrant 
doing so.   
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In circumstances where the questionnaire responses are illegible or ambiguous, that 
response will not be included in the analysis.   
 
7. IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about the research, please feel free to contact  
1.  Rochelle A Ganesh: Principal Investigator 
Mount Ayliff Hospital, Pharmacy Department 
Telephone: 039 254 0230 (Ext 129) 
 
2.  Mr Greg Munro: Study Leader 
 
3.  Mr J Ntanzi: Quality Assurance Assistant Director 
Mount Ayliff Hospital, Quality Assurance and Infection Control Department 
Telephone: 039 254 0230 (Ext 119) 
 
 
8.   RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue participation without penalty.  
You are not waiving any legal claims, rights or remedies because of your participation in this 
research study.  If you have questions regarding your rights as a research subject, contact 
Ms Maléne Fouché [mfouche@sun.ac.za; 021 808 4622] at the Division for Research 
Development. 
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SIGNATURE OF RESEARCH SUBJECT OR LEGAL REPRESENTATIVE 
 
The information above was described to [me/the subject/the participant] by [name of 
relevant person] in [Afrikaans/English/Xhosa/other] and [I am/the subject is/the participant 
is]  in command of this language or it was satisfactorily translated to [me/him/her].  [I/the 
participant/the subject] was given the opportunity to ask questions and these questions 
were answered to [my/his/her] satisfaction.  
 
[I hereby consent voluntarily to participate in this study/I hereby consent that the 
subject/participant may participate in this study.] I have been given a copy of this form. 
 
________________________________________ 
Name of Subject/Participant 
 
________________________________________ 
Name of Legal Representative (if applicable) 
 
________________________________________   ______________ 
Signature of Subject/Participant or Legal Representative  Date 
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SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to __________________ 
[name of the subject/participant] and/or [his/her] representative ____________________ 
[name of the representative]. [He/she] was encouraged and given ample time to ask me any 
questions. This conversation was conducted in [Afrikaans/*English/*Xhosa/*Other] and [no 
translator was used/this conversation was translated into ___________ by 
_______________________]. 
 
________________________________________  ______________ 
Signature of Investigator                Date 
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Questionnaire for the 
Assessment of TB screening practices and infection control at Mount Ayliff Hospital 
 
Instructions for completion: put a cross in the box most applicable to you and your area of 
work 
1.  What is your occupation? 
Doctor Nurse – Surgical Wards Pharmacist 
Nurse – Out-patients 
department 
Nurse – Maternity Ward X-ray attendant / 
Radiographer 
Nurse – Casualty Nurse – Theatre  
Nurse – TB Wards Nurse – ARV Clinic  
 
2.  Which areas are you responsible for? 
ARV Clinic  Surgical Wards Pharmacy 
Out-patients department Maternity Ward X-ray Department 
Casualty Theatre HIV/AIDS Counselling and 
Testing 
TB Wards   
 
3.  How risky is your area of work with regard to TB transmission? 
  1 2 3 
 
 
1.  How many patients are seen daily in your area of 
work? 
 
2.  How many TB suspects/patients do you estimate 
are seen daily in your area of work? 
 
0-50 
 
 
<5% 
50-100 
 
 
5-15% 
>100  
 
 
>15% 
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 3.  What is the average patient waiting time in your 
area of work? 
0-1 hr 1-2 hrs >2 hrs 
     
 4.  In your opinion, how good is the 
airflow/ventilation of the waiting area in your area 
of work? 
Good Average Bad 
     
     
 
 
4. Strategies to reduce generation of infectious aerosols (administrative controls) 
     
1. Are patients screened for TB if they present with  
cough >2 weeks as they enter your facility? 
 
Yes Occasionally No 
2. Are patients educated in cough hygiene if they are 
coughing? 
 
Yes Occasionally No 
3. If patients are coughing, are they provided with 
masks/tissues to reduce generation of infectious 
aerosols in the hospital ? 
 
Yes Occasionally No 
4. Are patients who are TB suspects/patients 
separated from those who are not? (i.e. separate 
waiting areas/ separate locations in wards or 
separate wards) 
 
Yes Occasionally No 
5. Are TB suspects given priority to ensure shorter 
waiting times in outpatient facilities 
 
Yes Occasionally No 
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6. Are you aware of the need for ‘early TB diagnosis’ 
(e.g. through emphasis in staff training?) 
 
Yes  No 
7. Are there separate and ventilated facilities for 
sputum collection from suspects?  
 
Yes Yes, but not 
ventilated 
No 
8. Is there a ‘fast-queue’ for collection of sputum 
smear results? 
Yes No, but 
collection of 
results is 
fast 
No 
9. What is the laboratory turn-around time for 
sputum AFB/microscopy? 
<48 
hours 
48-72 hours >72 
hours 
 
5. Strategies to reduce/eliminate infectious aerosols after generation (environmental 
controls) 
     
1. Are suspected TB inpatients able and 
encouraged to spend time outside during 
daylight hours? 
 
Yes Occasionally No, it’s 
not 
possible 
2. Are the windows in your area of work able to 
open?  
 
Yes Some No 
3. Are the windows in your area of work kept 
open?  
 
Yes Occasionally No 
4. Are fans to increase circulation of air used in 
your area of work? 
Yes Occasionally No 
5. Are you aware that when you consult or work 
with patients, the direction of air-flow should 
Yes Yes, but I 
don’t 
No 
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be towards the patient, and from behind you?   
 
 
 
 
 
always do it 
6.   Are ultra-violet germicidal radiation facilities in     
use in the area where your work? 
Yes, 
always 
Occasionally  No 
 
6.  Strategies to reduce inhalation of infectious aerosols (personal protective equipment) 
     
1. Are you screened for TB infection and disease 
as part of your conditions of employment? 
 
 
 
Regularly No, but I have 
done this in 
my personal 
capacity 
No 
2. Are you encouraged by your line managers to 
know your HIV status? 
 
Yes, 
regularly 
Occasionally No 
3. Are you aware of the risks of TB infection and 
disease to people who are living with HIV? 
 
Yes Some 
knowledge 
No 
4. Are you trained in TB infection control?  
 
Regularly Occasionally No 
5. Are you trained in recognition of TB suspects 
and diagnosis of TB? 
 
Regularly Occasionally No 
6. Are N95 masks available? 
 
 
Yes, 
always 
Yes, 
occasionally 
No 
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7. Are you trained in the use of N95 masks? 
 
 
 
    How often do you use N95 masks? 
Yes 
Always 
 
 
Always 
 
Occasionally 
 
 
Occasionally 
No, 
not at 
all 
 
Not at 
all 
       
 
 
7. Integrated HIV/AIDS and TB services 
 
1.  How many co-infected HIV/TB patients are seen 
daily in your area of work? 
 
2.  Do you provide treatment and adherence 
counselling prior to TB therapy initiation? 
 
3.  Do you practice a Directly Observed Therapy Short 
course (DOTS) approach to aid compliance and 
adherence in patients on ARVs? 
 
4.  Do you actively screen for HIV in TB patients? 
 
 
5.  Do you actively screen for TB in HIV patients? 
 
 
6.  Do you provide Isoniazid Prophylaxis to HIV patients 
<5 
 
 
Yes 
 
 
Yes  
 
 
 
Always  
 
 
Always 
 
5-15 
 
 
 
 
 
 
 
 
 
Occasionally 
 
 
Occasionally 
 
>15 
 
 
No  
 
 
No 
 
 
 
Usually 
not 
 
Usually 
not 
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on ARVs? 
 
 
Always  
 
Occasionally    
 
 
 
 
Usually 
not 
 
 
 
 
 
 Thank you for completing this questionnaire.   
If you have any enquiries, and to return all questionnaires, please contact Rochelle A 
Ganesh at Mount Ayliff Hospital Pharmacy Department or telephonically on 039 254 0230 
(Ext 129). 
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